Hypertension and NAFLD risk: Insights from the NHANES 2017-2018 and Mendelian randomization analyses
- PMID: 37455323
- PMCID: PMC10876227
- DOI: 10.1097/CM9.0000000000002753
Hypertension and NAFLD risk: Insights from the NHANES 2017-2018 and Mendelian randomization analyses
Abstract
Background: Hypertension and non-alcoholic fatty liver disease (NAFLD) share several pathophysiologic risk factors, and the exact relationship between the two remains unclear. Our study aims to provide evidence concerning the relationship between hypertension and NAFLD by analyzing data from the National Health and Nutrition Examination Survey (NHANES) 2017-2018 and Mendelian randomization (MR) analyses.
Methods: Weighted multivariable-adjusted logistic regression was applied to assess the relationship between hypertension and NAFLD risk by using data from the NHANES 2017-2018. Subsequently, a two-sample MR study was performed using the genome-wide association study (GWAS) summary statistics to identify the causal association between hypertension, systolic blood pressure (SBP), diastolic blood pressure (DBP), and NAFLD. The primary inverse variance weighted (IVW) and other supplementary MR approaches were conducted to verify the causal association between hypertension and NAFLD. Sensitivity analyses were adopted to confirm the robustness of the results.
Results: A total of 3144 participants were enrolled for our observational study in NHANES. Weighted multivariable-adjusted logistic regression analysis suggested that hypertension was positively related to NAFLD risk (odds ratio [OR] = 1.677; 95% confidence interval [CI], 1.159-2.423). SBP ≥130 mmHg and DBP ≥80 mmHg were also significantly positively correlated with NAFLD. Moreover, hypertension was independently connected with liver steatosis ( β = 7.836 [95% CI, 2.334-13.338]). The results of MR analysis also supported a causal association between hypertension (OR = 7.203 [95% CI, 2.297-22.587]) and NAFLD. Similar results were observed for the causal exploration between SBP (OR = 1.024 [95% CI, 1.003-1.046]), DBP (OR = 1.047 [95% CI, 1.005-1.090]), and NAFLD. The sensitive analysis further confirmed the robustness and reliability of these findings (all P >0.05).
Conclusion: Hypertension was associated with an increased risk of NAFLD.
Copyright © 2024 The Chinese Medical Association, produced by Wolters Kluwer, Inc. under the CC-BY-NC-ND license.
Conflict of interest statement
None.
Figures

Similar articles
-
Depression and the risk of non-alcohol fatty liver disease: Results from a cross-sectional study and a Mendelian randomization analysis.J Affect Disord. 2024 Dec 1;366:300-307. doi: 10.1016/j.jad.2024.08.189. Epub 2024 Aug 29. J Affect Disord. 2024. PMID: 39216642
-
Age at menarche and risk of non-alcoholic fatty liver disease: Insights from the NHANES 2017-2020 and Mendelian randomization analyses.Exp Gerontol. 2025 Jun 1;204:112748. doi: 10.1016/j.exger.2025.112748. Epub 2025 Apr 5. Exp Gerontol. 2025. PMID: 40194671
-
Non-alcoholic fatty liver disease and gestational diabetes mellitus: a bidirectional two-sample mendelian randomization study.BMC Endocr Disord. 2024 Mar 20;24(1):40. doi: 10.1186/s12902-024-01569-6. BMC Endocr Disord. 2024. PMID: 38504196 Free PMC article.
-
Waist-to-hip ratio and nonalcoholic fatty liver disease: a clinical observational and Mendelian randomization analysis.Front Nutr. 2024 Nov 1;11:1426749. doi: 10.3389/fnut.2024.1426749. eCollection 2024. Front Nutr. 2024. PMID: 39555187 Free PMC article.
-
Homocysteine, folate, and nonalcoholic fatty liver disease: a systematic review with meta-analysis and Mendelian randomization investigation.Am J Clin Nutr. 2022 Dec 19;116(6):1595-1609. doi: 10.1093/ajcn/nqac285. Am J Clin Nutr. 2022. PMID: 36205540
Cited by
-
Nonlinear association of a composite metabolic index (ZJU index) with hypertension: a cross-sectional study of NHANES 2003-2018.Front Cardiovasc Med. 2025 Jun 18;12:1608648. doi: 10.3389/fcvm.2025.1608648. eCollection 2025. Front Cardiovasc Med. 2025. PMID: 40606025 Free PMC article.
-
Association of depression with severe non-alcoholic fatty liver disease: evidence from the UK Biobank study and Mendelian randomization analysis.Sci Rep. 2024 Nov 19;14(1):28561. doi: 10.1038/s41598-024-79100-z. Sci Rep. 2024. PMID: 39557910 Free PMC article.
-
Association between neutrophil-to-high-density lipoprotein cholesterol ratio and non-alcoholic fatty liver disease or metabolic dysfunction-associated steatotic liver disease: evidence from NHANES 2017-2020.Front Med (Lausanne). 2025 Jan 15;11:1491858. doi: 10.3389/fmed.2024.1491858. eCollection 2024. Front Med (Lausanne). 2025. PMID: 39882525 Free PMC article.
-
The relationship between dietary sodium intake and all-cause mortality in patients with non-alcoholic fatty liver disease: a cohort study from NHANES 2003-2018.Front Nutr. 2025 Apr 23;12:1530025. doi: 10.3389/fnut.2025.1530025. eCollection 2025. Front Nutr. 2025. PMID: 40336965 Free PMC article.
-
Relationship between hypothyroidism and chronic kidney disease: Results from the National Health and Nutrition Examination Survey 2007 to 2012 and Mendelian randomization study.Medicine (Baltimore). 2024 Dec 20;103(51):e40925. doi: 10.1097/MD.0000000000040925. Medicine (Baltimore). 2024. PMID: 39705485 Free PMC article.
References
-
- Powell EE, Wong VW, Rinella M. Non-alcoholic fatty liver disease. Lancet 2021;397: 2212–2224. doi: 10.1016/S0140-6736(20)32511-3. - PubMed
-
- Lazarus JV Mark HE Anstee QM Arab JP Batterham RL Castera L, et al. . Advancing the global public health agenda for NAFLD: A consensus statement. Nat Rev Gastroenterol Hepatol 2022;19: 60–78. doi: 10.1038/s41575-021-00523-4. - PubMed
-
- Di Bonito P Pacifico L Licenziati MR Maffeis C Morandi A Manco M, et al. . Elevated blood pressure, cardiometabolic risk and target organ damage in youth with overweight and obesity. Nutr Metab Cardiovasc Dis 2020;30: 1840–1847. doi: 10.1016/j.numecd.2020.05.024. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical